If you have started researching weight loss medications in the Tampa area, you have probably run into two names again and again: semaglutide and tirzepatide. Both are prescription injectables, both are used in physician-supervised weight management, and both come up in almost every conversation we have with new patients. The natural question is which one is right for you.
The honest answer is that it depends on your health history, your goals, and a physician's assessment. This guide walks through how the two medications work, the differences patients most often ask about, and how transparent, cash-pay care is structured at Lavena Health here in Temple Terrace. Nothing below is a substitute for a medical consultation, but it should help you arrive at that conversation better informed.
How semaglutide and tirzepatide work
Both medications belong to a class of drugs that influence the same hormonal signals your body already uses to regulate appetite and blood sugar. In plain terms, they help many patients feel full sooner, stay full longer, and feel less pulled toward frequent snacking. That reduced appetite is a large part of why people tend to eat less without the constant hunger that so often derails other approaches.
There is a meaningful difference in how they do this. Semaglutide acts on a single hormonal pathway, while tirzepatide acts on two related pathways at once. This dual-versus-single distinction is the technical difference most articles focus on, but for patients the practical takeaway is simpler: these are two related tools, and a physician helps match the tool to the person.
Both are prescription medications. Neither is meant to be used on its own without oversight, and neither is a shortcut around nutrition and follow-up. They work best as one part of a supervised plan.
Key differences patients ask about
Mechanism and appetite effects
Because tirzepatide engages two pathways rather than one, some patients and clinicians describe a difference in how appetite responds. That said, individual response varies widely. Some people do very well on semaglutide and see no reason to change; others may be better suited to tirzepatide. This is exactly the kind of judgment that benefits from a physician who knows your history rather than a one-size-fits-all recommendation.
Dosing and titration
Both medications are typically started at a low dose and increased gradually over time, a process called titration. The goal of going slowly is to let your body adjust and to manage side effects thoughtfully. Your specific starting point and pace are set with your physician, and plans are adjusted based on how you respond rather than a fixed schedule.
Side effect profiles
The side effects patients most commonly report with both medications tend to be gastrointestinal, such as nausea or changes in digestion, and they are often most noticeable early on or after a dose increase. This is one of the clearest reasons supervision matters. A physician can adjust your plan, slow a titration step, or address a side effect before it becomes a reason to quit. Sourcing medication without that support removes exactly the guidance that keeps people on track.
What results may look like
It is important to be careful with expectations. On average, many patients on physician-supervised GLP-1 programs see meaningful, gradual weight change over a period of months. But results are not guaranteed, and they are not uniform. Outcomes depend heavily on adherence, nutrition, activity, sleep, and consistent follow-up.
This is where an ongoing physician relationship earns its keep. Weight loss is rarely a straight line, and the plan that works in month one may need adjusting by month four. Regular monitoring lets your physician fine-tune the approach, address plateaus, and keep the plan safe over time. You can read more about what supervised care looks like on our medical weight loss page.
Transparent pricing at Lavena Health
One of the most common frustrations we hear is that patients cannot get a straight answer on cost anywhere else. At Lavena Health, our pricing is published and predictable. Semaglutide programs start from $175 per month, and tirzepatide programs start from $225 per month. There is no insurance filing and no surprise billing after the fact.
That monthly price is a program, not just a prescription. It includes physician oversight, titration guidance, and follow-up visits, so the cost you see reflects the care you actually receive. If you would like to spread the cost out, we also offer financing options. We think this kind of transparency is a fairer way to plan than navigating insurance denials and pharmacy markups that shift from month to month.
How we help you decide
Choosing between semaglutide and tirzepatide is not something you should have to do alone from a search bar. Dr. Adeeb Saleh is a board-certified emergency medicine physician who is also A4M-certified in medical weight loss, and the decision is made together during a consultation.
A typical intake is a conversation. We review your health history, talk through your goals, and screen for anything that affects which medication is appropriate and how to start safely. From there, your physician recommends a path and sets a titration plan built around you. As a physician-owned, cash-pay clinic, our recommendations are driven by clinical judgment rather than billing constraints.
We serve patients across Temple Terrace, Tampa, and nearby communities including Brandon and Riverview. Wherever you are in the Tampa area, the process is the same.
Start a physician-guided weight loss plan
If you are weighing semaglutide against tirzepatide, the best next step is a low-pressure consultation where a physician can look at the full picture. You can book a consultation online or call us at (813) 805-8917, Monday through Friday, 9am to 5pm. There is no obligation to start, and no pressure to choose today. Our goal is simply to help you understand your options and, if it makes sense, begin a plan that is transparent, supervised, and built around your health.